Cargando...

Neuropathy-Inducing Effects of Eribulin Mesylate Versus Paclitaxel in Mice with Preexisting Neuropathy

Eribulin mesylate (E7389, INN:eribulin mesilate Halaven(®)) is a non-taxane microtubule dynamics inhibitor currently in clinical use for advanced breast cancer. Other microtubule-targeting agents for breast cancer, including paclitaxel and ixabepilone, display a common treatment dose-limiting toxici...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wozniak, Krystyna M., Wu, Ying, Farah, Mohamed H., Littlefield, Bruce A., Nomoto, Kenichi, Slusher, Barbara S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4073636/
https://ncbi.nlm.nih.gov/pubmed/23637052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12640-013-9394-3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!